Ozempic Shortage to Persist Until End of 2025: What You Need to Know

If you or someone you know relies on Ozempic, there’s important news regarding its availability. According to Novo Nordisk, the manufacturer of Ozempic, the supply constraints will continue through the end of 2025. Here’s what you need to know about the situation and how it might affect you.

The Therapeutic Goods Administration (TGA) has shared that Novo Nordisk is actively working to increase manufacturing capacity to meet the growing global and Australian demand for Ozempic. However, scaling up production is a complex process that takes time, leaving the supply limited in the meantime.

Ozempic, a semaglutide product, is primarily prescribed to help manage type 2 diabetes for patients who are not adequately managed with other medications. It is used alongside a healthy diet and exercise. Another semaglutide product, Wegovy, is approved for chronic weight management, but it is also experiencing high demand.

Diabetes Australia has expressed its deep concern for individuals living with type 2 diabetes who are affected by this ongoing shortage. They are continuing to advocate for prioritizing access to Ozempic for those who need it most. Additionally, Diabetes Australia is urging the TGA to address shortages across various diabetes-related medicines and products to ensure Australians can rely on consistent supply chains in the future.

The TGA has issued recommendations for healthcare professionals to help manage the situation:

If you’re currently prescribed Ozempic or Wegovy, it’s essential to have open and proactive conversations with your healthcare provider. They can help you explore alternative medications or strategies to manage your condition during this period.

Additionally, keeping informed through reliable sources like the TGA website will ensure you’re up to date on any developments regarding the supply.

While Novo Nordisk is taking steps to address the global demand, it’s clear that restoring normal supply levels will take time. For now, healthcare providers and patients must work together to navigate these challenges. Diabetes Australia and the TGA are also continuing efforts to advocate for and manage the needs of Australians living with type 2 diabetes.

For more information, visit the TGA website or consult your healthcare provider for personalized advice.

By staying informed and working collaboratively, we can ensure that individuals affected by this shortage receive the care they need.